Sort
326,823 grants matching “clinical trial”
Network of Excellence in Neuroscience Clinical Trials (NeuroNEXT) - DCC
$1,763,568Christopher S. Coffey · University Of Iowa · U01 · FY2020 · NS
Vaccine Production Core
$1,763,524Thomas N Denny · Duke University · U19 · FY2007 · AI
Phase 1 study of oral epigallocatechin-3-gallate (EGCG) in IPF patients
$1,763,207Fernando J Martinez · Univ Of Massachusetts Med Sch Worcester · R33 · FY2025 · HL
Integrative analysis and modeling of human immune responses and pathologies
$1,763,154John Tsang · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
Pathogenesis and Treatment of HIV Infection
$1,763,103H. Clifford Lane · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
Anesthetic-Induced Cardiac Preconditioning
$1,762,868Zeljko J. Bosnjak · Medical College Of Wisconsin · P01 · FY2012 · GM
Mayo Clinic Ovarian Cancer SPORE
$1,762,703Scott H Kaufmann · Mayo Clinic Rochester · P50 · FY2021 · CA
Penn PET Addiction Center of Excellence (Penn PACE)
$1,762,654Robert H Mach · University Of Pennsylvania · P30 · FY2019 · DA
ADULT AIDS CLINICAL TRIALS UNIT
$1,762,555New York University School Of Medicine · U01 · FY2000 · AI
University of Rochester HIV/AIDS Clinical Trials Unit
$1,762,495Michael C Keefer · University Of Rochester · UM1 · FY2021 · AI
Structure-based Drug Design for Smallpox Therapy
$1,762,466Alex Y Strongin · Sanford Burnham Prebys Medical Discovery Institute · U01 · FY2007 · AI
Enhanced COhort methods for HIV Research and Epidemiology (ENCORE) among transgender women in the United States
$1,762,325Andrea L Wirtz · Johns Hopkins University · R01 · FY2022 · AI
MethLock vs. heparin as dialysis catheter lock
$1,762,060Stephen R Ash · Ash Access Technology, Inc. · R44 · FY2007 · DK
Hutchinson-Gilford Progeria syndrome--a model for the genetics of aging.
$1,761,984Francis Sellers Collins · Human Genome Research · Z01 · FY2007 · HG
ShRNA-Based Targeting of mAKAPò in Heart Failure
$1,761,984Federico Cividini · Cardiac Rsk3 Inhibitors, Llc · R44 · FY2021 · HL
Development of antibody engineering-based cancer therapies
$1,761,905Mitchell Ho · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
NK cells, their receptors, transplantation and cancer therapy
$1,761,898Jeffrey S Miller · University Of Minnesota · P01 · FY2019 · CA
Enhanced COhort methods for HIV Research and Epidemiology (ENCORE) among transgender women in the United States
$1,761,882Andrea L Wirtz · Johns Hopkins University · R01 · FY2024 · AI
Clinical Program in Pediatric Sarcomas
$1,761,615Crystal Mackall · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Immunobiology and Immunotherapy of Pediatric Tumors
$1,761,615Crystal Mackall · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Type 1 Diabetes TrialNet
$1,761,472University Of Miami School Of Medicine · U01 · FY2002 · DK
Design and Synthesis of HIV Integrase as Potential Anti-AIDS Drugs
$1,761,393Terrence Burke · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Preclinical development of myosolvins, a new class of medicine for asthma
$1,761,373Julian Solway · University Of Chicago · UH2 · FY2014 · HL
Southern Consortium Node of the Clinical Trials Network
$1,761,373Kathleen Theresa Brady · Medical University Of South Carolina · UG1 · FY2022 · DA
Reprogramming PDAC tumor microenvironment to improve immunotherapy
$1,761,342Rakesh K. Jain · Massachusetts General Hospital · U01 · FY2017 · CA